Status:

UNKNOWN

RBD Longitudinal as Prognostic for PD

Lead Sponsor:

The University of Texas Health Science Center, Houston

Conditions:

Rapid Eye Movement Sleep Behavior Disorder

Eligibility:

All Genders

35-70 years

Brief Summary

* Purpose - to validate a combination of biological and clinical markers in the rapid-eye-movement (REM) sleep behavior disorder (RBD) population as indicative of the pre-symptomatic stage of Parkinso...

Detailed Description

Enrollment of PD and PS cohorts is complete. Currently enrolling only confirmed RBD and Controls.

Eligibility Criteria

Inclusion

  • 35-70 year old men \& women
  • (1) Diagnosis of idiopathic RBD (see AASM criteria), 2) Normal control or control with a non-neurodegenerative disorder, age and gender-matched to (1)
  • Gives written informed consent
  • Pregnant women are not excluded, but will be identified by HCG.

Exclusion

  • a A diagnosis of any non-Parkinsonian Neurodegenerative Disease.
  • b. Any unstable or uncontrolled medical or psychiatric condition.
  • c. Parasomnia or RBD not idiopathic, eg., secondary to metabolic derangement or medicine effect.
  • d. Renal (creatinine over 1.6) or hepatic insufficiency (LFT significantly out of range), or a history of significant uncontrolled cardiac disease.
  • e. Significant dementia (MMSE\<25 of 30 or MOCA\<25/30) that would interfere with study procedures or informed consent.
  • f. Any reason which, in the opinion of the PI, would increase the risk or decrease the value of any study procedure.
  • g. fMRI will not be performed for anyone for whom the screening questionnaire indicates is ineligible for MRI imaging.

Key Trial Info

Start Date :

January 1 2009

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

May 1 2025

Estimated Enrollment :

164 Patients enrolled

Trial Details

Trial ID

NCT00817726

Start Date

January 1 2009

End Date

May 1 2025

Last Update

November 29 2023

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University of texas Health Science Center at Houston

Houston, Texas, United States, 77030

RBD Longitudinal as Prognostic for PD | DecenTrialz